Dana-Farber Cancer Institute, INC.

Dana-Farber Cancer Institute, INC. was paid $24K by Medicaid between Jan 2018 and Aug 2024, across 9 billing codes. Its largest line is L8000, Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type — 67% of everything it billed.

33Billing provider infoDANA-FARBER CANCER INSTITUTE, INC.
BOSTON, MA 02115

33aNPI1225079940assigned 06/10/2006

33bProvider typeDurable Medical Equipment & Medical Supplies

28Total paid$24K

24GClaims1,518

24DCodes billed9

24AFirst – last monthJan 2018 – Aug 2024

Compared with peers

Next to other Durable Medical Equipment & Medical Supplies providers in Massachusetts

Rank by total paid#108 of 297

Median peer was paid$0.00

This provider vs. median0.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	250	$4K
2019	228	$2K
2020	75	$1K
2021	619	$6K
2022	92	$698.93
2023	156	$6K
2024incomplete	98	$3K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	67%	941	543	$16K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	21%	114	107	$5K
L8030	Breast prosthesis, silicone or equal, without integral adhesive	11%	15	13	$3K
80053	Comprehensive metabolic panel	<1%	57	54	$28.89
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	73	64	$28.36
82728		<1%	13	13	$24.86
83540		<1%	13	13	$11.80
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	0%	276	254	$0.00
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	0%	16	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDEMBINSKI, PAUL (SR. DIRECTOR OF PFS)

Parent organizationDANA-FARBER CANCER INSTITUTE, INC.

Same official

Other billing entities under DEMBINSKI, PAUL

Full network →

Provider	Location	Paid
Dana-Farber Cancer Institute, INC.	Boston, MA	$240.21M
Dana-Farber Cancer Institute, INC.	Boston, MA	$4.81M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.